Mikart Announces Compliance with DSCSA Serialization Requirement
The company announced that it is fully compliant with the 2017–2023 serialization and aggregation requirements.
On June 5, 2017, Mikart announced that it is fully compliant with 2017–2023 serialization and aggregation requirements in the Drug Supply Chain Security Act. The Atlanta-based company has partnered with Optel Vision, which makes hardware and software that generates, reads, applies, and verifies codes throughout the entire packaging process, and TraceLink, the data warehouse that makes information contained in the serialization codes available to every point in the pharmaceutical supply chain.
Mikart offers a full range of services in addition to serialization and aggregation, including pharmaceutical development, clinical trial manufacturing and packaging, regulatory submissions, commercial scale manufacturing, and packaging solutions.
Source: Mikart
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
